These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 37818931)

  • 21. Platinum-induced ototoxicity in pediatric cancer survivors: GSTP1 c.313A>G variant association.
    Sherief LM; Rifky E; Attia M; Ahmed R; Kamal NM; Oshi MAM; Hanna D
    Medicine (Baltimore); 2022 Nov; 101(45):e31627. PubMed ID: 36397425
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ototoxicity in children with high-risk neuroblastoma: prevalence, risk factors, and concordance of grading scales--a report from the Children's Oncology Group.
    Landier W; Knight K; Wong FL; Lee J; Thomas O; Kim H; Kreissman SG; Schmidt ML; Chen L; London WB; Gurney JG; Bhatia S
    J Clin Oncol; 2014 Feb; 32(6):527-34. PubMed ID: 24419114
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention and restoration of hearing loss associated with the use of cisplatin.
    Chirtes F; Albu S
    Biomed Res Int; 2014; 2014():925485. PubMed ID: 25140325
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Platinum-induced ototoxicity: a review of prevailing ototoxicity criteria.
    Waissbluth S; Peleva E; Daniel SJ
    Eur Arch Otorhinolaryngol; 2017 Mar; 274(3):1187-1196. PubMed ID: 27245751
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Strategies to reduce the risk of platinum containing antineoplastic drug-induced ototoxicity.
    Mukherjea D; Dhukhwa A; Sapra A; Bhandari P; Woolford K; Franke J; Ramkumar V; Rybak L
    Expert Opin Drug Metab Toxicol; 2020 Oct; 16(10):965-982. PubMed ID: 32757852
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The genetic vulnerability to cisplatin ototoxicity: a systematic review.
    Tserga E; Nandwani T; Edvall NK; Bulla J; Patel P; Canlon B; Cederroth CR; Baguley DM
    Sci Rep; 2019 Mar; 9(1):3455. PubMed ID: 30837596
    [TBL] [Abstract][Full Text] [Related]  

  • 27. COAST (Cisplatin ototoxicity attenuated by aspirin trial): A phase II double-blind, randomised controlled trial to establish if aspirin reduces cisplatin induced hearing-loss.
    Crabb SJ; Martin K; Abab J; Ratcliffe I; Thornton R; Lineton B; Ellis M; Moody R; Stanton L; Galanopoulou A; Maishman T; Geldart T; Bayne M; Davies J; Lamb C; Popat S; Joffe JK; Nutting C; Chester J; Hartley A; Thomas G; Ottensmeier C; Huddart R; King E
    Eur J Cancer; 2017 Dec; 87():75-83. PubMed ID: 29128692
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence and risk factors for ototoxicity after cisplatin-based chemotherapy.
    Sanchez VA; Dinh PC; Rooker J; Monahan PO; Althouse SK; Fung C; Sesso HD; Einhorn LH; Dolan ME; Frisina RD; Travis LB
    J Cancer Surviv; 2023 Feb; 17(1):27-39. PubMed ID: 36637632
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platinum-containing regimens for triple-negative metastatic breast cancer.
    Egger SJ; Chan MMK; Luo Q; Wilcken N
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD013750. PubMed ID: 33084020
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cisplatin-induced ototoxicity: Updates on molecular mechanisms and otoprotective strategies.
    Tang Q; Wang X; Jin H; Mi Y; Liu L; Dong M; Chen Y; Zou Z
    Eur J Pharm Biopharm; 2021 Jun; 163():60-71. PubMed ID: 33775853
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ototoxicity Review: A Growing Number of Non-Platinum-Based Chemo- and Immunotherapies.
    Naples JG; Rice-Narusch W; Watson NW; Ghulam-Smith M; Holmes S; Li D; Jalisi S
    Otolaryngol Head Neck Surg; 2023 Apr; 168(4):658-668. PubMed ID: 35439087
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ototoxicity and long-term hearing outcome in pediatric patients receiving cisplatin.
    Sriyapai T; Thongyai K; Phuakpet K; Vathana N; Buaboonnam J; Sanpakit K
    Turk J Pediatr; 2022; 64(3):531-541. PubMed ID: 35899566
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk factors associated with cisplatin-induced ototoxicity in Japanese patients with solid tumors.
    Okada H; Kitagawa K
    Cancer Med; 2023 Apr; 12(7):7904-7910. PubMed ID: 36567514
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidence and associated risk factors for platinum-induced ototoxicity in pediatric patients.
    Waissbluth S; Del Valle Á; Chuang A; Becker A
    Int J Pediatr Otorhinolaryngol; 2018 Aug; 111():174-179. PubMed ID: 29958605
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulation of NAD
    Zhan T; Xiong H; Pang J; Zhang W; Ye Y; Liang Z; Huang X; He F; Jian B; He W; Gao Y; Min X; Zheng Y; Yang H
    Toxicol Lett; 2021 Oct; 349():115-123. PubMed ID: 34089817
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overview of cisplatin-induced neurotoxicity and ototoxicity, and the protective agents.
    Santos NAGD; Ferreira RS; Santos ACD
    Food Chem Toxicol; 2020 Feb; 136():111079. PubMed ID: 31891754
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase 1 study to evaluate safety, tolerability and pharmacokinetics of a novel intra-tympanic administered thiosulfate to prevent cisplatin-induced hearing loss in cancer patients.
    Viglietta V; Shi F; Hu QY; Ren Y; Keilty J; Wolff H; McCarthy R; Kropp J; Weber P; Soglia J
    Invest New Drugs; 2020 Oct; 38(5):1463-1471. PubMed ID: 32157599
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ototoxicity in childhood: Recommendations of the CODEPEH (Commission for the Early Detection of Childhood Hearing Loss) for prevention and early diagnosis.
    Núñez-Batalla F; Jáudenes-Casaubón C; Sequí-Canet JM; Vivanco-Allende A; Zubicaray-Ugarteche J
    Acta Otorrinolaringol Esp (Engl Ed); 2022; 73(4):255-265. PubMed ID: 35872300
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Audiological Monitoring in Children Treated with Platinum Chemotherapy.
    Fetoni AR; Ruggiero A; Lucidi D; De Corso E; Sergi B; Conti G; Paludetti G
    Audiol Neurootol; 2016; 21(4):203-211. PubMed ID: 27286730
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systematic Review and Meta-Analysis of the Influence of Genetic Variation on Ototoxicity in Platinum-Based Chemotherapy.
    Hong DZ; Ong TCC; Timbadia DP; Tan HTA; Kwa ED; Chong WQ; Goh BC; Loh WS; Loh KS; Tan EC; Tay JK
    Otolaryngol Head Neck Surg; 2023 Jun; 168(6):1324-1337. PubMed ID: 36802061
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.